SMTL ID : 4moq.1

Pyranose 2-oxidase V546C mutant with 2-fluorinated galactose

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.60 Å

Oligo State

homo-tetramer

Ligands

4 x FDA: DIHYDROFLAVINE-ADENINE DINUCLEOTIDE(Covalent)

FDA.1: 34 residues within 4Å: Chain A: V.52, G.53, G.55, P.56, I.57, F.75, D.76, I.77, I.107, L.111, T.158, R.159, V.160, G.163, M.164, S.165, H.167, W.168, T.169, C.170, A.171, V.281, C.283, T.319, A.320, H.324, F.454, L.547, G.582, C.583, N.593, P.594, T.595 Ligands: 2FG.2 29 PLIP interactions: 29 interactions with chain A Hydrophobic interactions: A:I.107, A:L.111, A:W.168, A:F.454, A:L.547 Hydrogen bonds: A:G.55, A:I.57, A:G.58, A:I.77, A:T.158, A:V.160, A:G.163, A:M.164, A:S.165, A:T.169, A:T.169, A:A.171, A:A.171, A:C.283, A:C.283, A:N.593, A:T.595, A:T.595, A:T.595 Water bridges: A:G.321, A:L.547, A:L.596 pi-Stacking: A:W.168, A:H.548 FDA.4: 35 residues within 4Å: Chain B: V.52, G.53, G.55, P.56, I.57, F.75, D.76, I.77, I.107, L.111, T.158, R.159, V.160, G.163, M.164, S.165, H.167, W.168, T.169, C.170, A.171, V.281, C.283, T.319, A.320, G.321, H.324, F.454, L.547, G.582, C.583, N.593, P.594, T.595 Ligands: 2FG.5 29 PLIP interactions: 29 interactions with chain B Hydrophobic interactions: B:I.107, B:L.111, B:W.168, B:F.454, B:L.547 Hydrogen bonds: B:G.55, B:I.57, B:G.58, B:I.77, B:G.78, B:T.158, B:V.160, B:G.163, B:M.164, B:S.165, B:T.169, B:T.169, B:A.171, B:A.171, B:C.283, B:C.283, B:N.593, B:T.595, B:T.595, B:T.595 Water bridges: B:L.547, B:L.596 pi-Stacking: B:W.168, B:H.548 FDA.7: 34 residues within 4Å: Chain C: V.52, G.53, G.55, P.56, I.57, F.75, D.76, I.77, I.107, L.111, T.158, R.159, V.160, G.163, M.164, S.165, H.167, W.168, T.169, C.170, A.171, V.281, C.283, T.319, A.320, H.324, F.454, L.547, G.582, C.583, N.593, P.594, T.595 Ligands: 2FG.8 29 PLIP interactions: 29 interactions with chain C Hydrophobic interactions: C:I.107, C:L.111, C:W.168, C:F.454, C:L.547 Hydrogen bonds: C:G.55, C:I.57, C:G.58, C:I.77, C:T.158, C:V.160, C:G.163, C:M.164, C:S.165, C:T.169, C:A.171, C:A.171, C:C.283, C:C.283, C:N.593, C:T.595, C:T.595, C:T.595 Water bridges: C:G.321, C:H.324, C:L.547, C:L.596 pi-Stacking: C:W.168, C:H.548 FDA.10: 35 residues within 4Å: Chain D: V.52, G.53, G.55, P.56, I.57, F.75, D.76, I.77, I.107, L.111, T.158, R.159, V.160, G.163, M.164, S.165, H.167, W.168, T.169, C.170, A.171, V.281, C.283, T.319, A.320, G.321, H.324, F.454, L.547, G.582, C.583, N.593, P.594, T.595 Ligands: 2FG.11 29 PLIP interactions: 29 interactions with chain D Hydrophobic interactions: D:I.107, D:L.111, D:W.168, D:F.454, D:L.547 Hydrogen bonds: D:G.55, D:I.57, D:G.58, D:I.77, D:G.78, D:T.158, D:V.160, D:G.163, D:M.164, D:S.165, D:T.169, D:A.171, D:A.171, D:C.283, D:C.283, D:N.593, D:T.595, D:T.595, D:T.595 Water bridges: D:H.324, D:L.547, D:L.596 pi-Stacking: D:W.168, D:H.548

6 x 2FG: 2-deoxy-2-fluoro-beta-D-galactopyranose(Non-covalent)

2FG.2: 13 residues within 4Å: Chain A: T.169, Q.448, H.450, D.452, F.454, Y.456, R.472, F.474, L.545, C.546, H.548, N.593 Ligands: FDA.1 9 PLIP interactions: 9 interactions with chain A Hydrogen bonds: A:Q.448, A:H.450, A:D.452, A:D.452, A:Y.456, A:L.545, A:N.593 Water bridges: A:F.454 Salt bridges: A:H.548 2FG.3: 6 residues within 4Å: Chain A: G.398, A.399, N.402, K.403, H.404, P.405 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:K.403, A:D.406 Water bridges: A:D.406 2FG.5: 13 residues within 4Å: Chain B: T.169, Q.448, H.450, D.452, F.454, Y.456, R.472, F.474, L.545, C.546, H.548, N.593 Ligands: FDA.4 9 PLIP interactions: 9 interactions with chain B Hydrogen bonds: B:Q.448, B:H.450, B:D.452, B:D.452, B:Y.456, B:L.545, B:N.593 Water bridges: B:T.169 Salt bridges: B:H.548 2FG.8: 13 residues within 4Å: Chain C: T.169, Q.448, H.450, D.452, F.454, Y.456, R.472, F.474, L.545, C.546, H.548, N.593 Ligands: FDA.7 8 PLIP interactions: 8 interactions with chain C Hydrogen bonds: C:T.169, C:Q.448, C:H.450, C:D.452, C:L.545, C:N.593 Water bridges: C:F.454 Salt bridges: C:H.548 2FG.9: 6 residues within 4Å: Chain C: G.398, A.399, N.402, K.403, H.404, P.405 3 PLIP interactions: 3 interactions with chain C Hydrogen bonds: C:K.403, C:D.406 Water bridges: C:D.406 2FG.11: 13 residues within 4Å: Chain D: T.169, Q.448, H.450, D.452, F.454, Y.456, R.472, F.474, L.545, C.546, H.548, N.593 Ligands: FDA.10 7 PLIP interactions: 7 interactions with chain D Hydrogen bonds: D:T.169, D:Q.448, D:H.450, D:D.452, D:L.545, D:N.593 Salt bridges: D:H.548

2 x MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID(Non-covalent)

MES.6: 7 residues within 4Å: Chain B: G.398, A.399, N.402, K.403, H.404, P.405, D.406 3 PLIP interactions: 3 interactions with chain B Hydrogen bonds: B:H.404, B:H.404 Water bridges: B:D.406 MES.12: 7 residues within 4Å: Chain D: G.398, A.399, N.402, K.403, H.404, P.405, D.406 3 PLIP interactions: 3 interactions with chain D Hydrogen bonds: D:H.404, D:H.404 Water bridges: D:D.406

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Tan, T.C. et al., Structural Basis for Binding of Fluorinated Glucose and Galactose to Trametes multicolor Pyranose 2-Oxidase Variants with Improved Galactose Conversion. Plos One (2014)

Release Date

2014-02-05

Peptides

Pyranose 2-oxidase: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
A

D
B

Pyranose 2-oxidase

Related Entries With Identical Sequence